Similar Search Results

Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply

Liljas, Bengt - In: The European Journal of Health Economics 11 (2010) 6, pp. 597-598

Persistent link: https://www.econbiz.de/10008775860

Nonmedical economic consequences attributable to visual impairment

Lafuma, Antoine; Brezin, Antoine; Fagnani, Francis; … - In: The European Journal of Health Economics 7 (2006) 3, pp. 158-164

Persistent link: https://www.econbiz.de/10005167153

The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration

Ke, Kathleen - In: The European Journal of Health Economics 11 (2010) 6, pp. 525-531

Persistent link: https://www.econbiz.de/10008775865

Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France

Serrier, Hassan; Sultan-Taieb, Hélène; Luce, Danièle; … - In: The European Journal of Health Economics 15 (2014) 6, pp. 661-673

Our assessment shows the magnitude of the economic impact of occupational respiratory cancers. It allows comparisons between countries and provides valuable information for policy-makers responsible for defining public health priorities. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014

Persistent link: https://www.econbiz.de/10010993854

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany

Ultsch, Bernhard; Köster, Ingrid; Reinhold, Thomas; … - In: The European Journal of Health Economics 14 (2013) 6, pp. 1015-1026

). We aimed to describe the epidemiology of HZ/PHN and to estimate HZ/PHN-related costs in the German statutory health … HZ-case caused on average €210 and €376 of costs from the payer and societal perspective, respectively. The development … of PHN generated additional costs of €1,123 (€1,645 societal perspective). Total annual HZ/PHN-related costs were …

Persistent link: https://www.econbiz.de/10010993913

Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study

Mostardt, Sarah; Hanhoff, Nikola; Wasem, Jürgen; … - In: The European Journal of Health Economics 14 (2013) 5, pp. 799-808

Expenditures for HIV-infection are driven mainly by drug costs. We identified several clinical variables influencing … the costs of HIV-treatment. This information could assist policymakers when allocating limited health care resources to …

Persistent link: https://www.econbiz.de/10010993926

Epilepsy in Sweden: health care costs and loss of productivity—a register-based approach

Bolin, Kristian; Lundgren, Anders; Berggren, Fredrik; … - In: The European Journal of Health Economics 13 (2012) 6, pp. 819-826

The per-patient cost of epilepsy is substantial. Thus, even though the prevalence of the illness is relatively small, the aggregated cost that epilepsy incurs on society is significant. </AbstractSection> Copyright Springer-Verlag 2012

Persistent link: https://www.econbiz.de/10010993943

The socioeconomic costs of mental illness in Spain

Oliva-Moreno, Juan; López-Bastida, Julio; … - In: The European Journal of Health Economics 10 (2009) 4, pp. 361-369

Persistent link: https://www.econbiz.de/10005015131

The impact of BMI on direct costs in Children and Adolescents: empirical findings for the German Healthcare System based on the KiGGS-study

Wenig, Christina - In: The European Journal of Health Economics 13 (2012) 1, pp. 39-50

Persistent link: https://www.econbiz.de/10010539280

Atrial fibrillation: the cost of illness in Sweden

Ericson, Lisa; Bergfeldt, Lennart; Björholt, Ingela - In: The European Journal of Health Economics 12 (2011) 5, pp. 479-487

Persistent link: https://www.econbiz.de/10009324975